EndoQuest Robotics
Manufacturing · Texas, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
9310 Kirby Dr Ste 100, Houston, Texas, 7...Phone Number
(281) 846-6597Website
www.endoquestrobotics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About EndoQuest Robotics
ENDOQUEST Robotics has developed the ENDOQUEST Endoluminal Surgical (ELS) System, the world's first endoluminal robotic surgical system that makes it possible for therapeutic endoscopists and surgeons to perform upper and lower gastrointestinal surgery less-invasively through a trans-oral or trans-anal approach. ENDOQUEST's robotic platform combines the flexibility of endoscopy that is able to navigate the curvature of patients' anatomy with instrumentation that allows the physician to use a conventional two-handed surgical technique. The ENDOQUEST ELS System has further potential applications in a range of minimally invasive surgeries including appendectomy and cholecystectomy that can be performed with no external incisions.Explore more
EndoQuest Robotics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is EndoQuest Robotics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when EndoQuest Robotics launches new products
Click to see if EndoQuest Robotics had a recent Job posting/layoffs
Earning: See what the market has to say on EndoQuest Robotics recently announced quarterly report
Check if EndoQuest Robotics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
EndoQuest Robotics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if EndoQuest Robotics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at EndoQuest Robotics
Funding: Get notified immidiatlly once EndoQuest Robotics has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to EndoQuest Robotics
Compare insights from companies similar to EndoQuest Robotics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
EndoQuest Robotics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
EndoQuest Robotics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about EndoQuest Robotics.
EndoQuest Robotics financials insights
Gather financial insights about EndoQuest Robotics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Series C
$42M
2025
Private Equity
$30.7M
EndoQuest Robotics Tech Stack
A closer look at the technologies used by EndoQuest Robotics
Most Recent Scoops
Person-Based
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Person-Based
Person-Based
EndoQuest Robotics News & Media
World’s First Fully Robotic Procedure by a Gastroenterologist Completed Using EndoQuest’s Endoluminal Surgical System in the PARADIGM Trial
Dr. Norio Fukami of Mayo Clinic, Arizona becomes first gastroenterologist to perform a robotic endoscopic submucosal dissection in the PARADIGM Trial Dr. Norio Fukami of Mayo Clinic, Arizona becomes first gastroenterologist to perform a robotic endoscopic submucosal dissection in the PARADIGM TrialEndoQuest Advances Multicenter PARADIGM Trial with Completion of Procedure at AdventHealth Orlando
Clinical progress expands to multiple sites with robotic endoscopic submucosal dissection procedure performed by Dr. Matthew Albert at AdventHealth Orlando Clinical progress expands to multiple sites with robotic endoscopic submucosal dissection procedure performed by Dr. Matthew Albert at AdventHealth OrlandoEndoQuest Robotics Secures Series D-2 Funding Round co-led by Crescent Enterprises and Dr. Fred Moll
New investment to accelerate pivotal PARADIGM Trial progress, FDA regulatory pathway, upper GI early feasibility studies, and progression of advanced endoluminal visualization systems New investment to accelerate pivotal PARADIGM Trial progress, FDA regulatory pathway, upper GI early feasibility studies, and progression of advanced endoluminal visualization systemsFirst Procedures Completed with EndoQuest’s Endoluminal Surgical System in PARADIGM Trial
EndoQuest Robotics commences its PARADIGM clinical trial with endoscopic submucosal dissection procedures at HCA Houston Healthcare Medical Center EndoQuest Robotics commences its PARADIGM clinical trial with endoscopic submucosal dissection procedures at HCA Houston Healthcare Medical Center
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding EndoQuest Robotics
Sign Up For FreeTo access detailed company insights
ENDOQUEST Robotics has developed the ENDOQUEST Endoluminal Surgical (ELS) System, the world's first endoluminal robotic surgical system that makes it possible for therapeutic endoscopists and surgeons to perform upper and lower gastrointestinal surgery less-invasively through a trans-oral or trans-anal approach. ENDOQUEST's robotic platform combine... Read More
